Eastern & Oriental Bhd (3417)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 0.755 |
|---|---|
| 52-week range | 0.605 – 0.860 |
| Return, 1 month / 3 months | −5.0% / −1.3% |
| Return, 1 year / 3 years | −4.8% / +34.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 26.7% |
| Worst drawdown (1 year) | -20.6% |
| Average daily value traded | 1.04M MYR |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eastern & Oriental Berhad is a Malaysian property developer with roots in Penang and operations centred on Kuala Lumpur and Penang. The company develops residential and mixed-use properties, including waterfront and marina-linked projects, and it also has interests in hospitality through hotels and resorts. Its customers are mainly home buyers, investors and businesses seeking residential, commercial and leisure space in Malaysia, and it is based in Malaysia.
The shares are listed on the Bursa Malaysia in Malaysia under the code 3417, and the price on this page is in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eastern & Oriental Bhd (3417) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 0.755 on 27 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 269 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.8% and over the last three months it fell 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 1.8% | ||
| From 52-week high | -8.5% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.3% | ||
| 6-month return | -3.2% | ||
| 12-month return, skipping the last month | 0.2% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.6% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 1.04M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 14 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | −5.0% |
| 3 months | −1.3% |
| 6 months | −3.2% |
| 1 year | −4.8% |
| 3 years | +34.7% |
| 5 years | +16.5% |
Signals
| 50-day / 200-day average | 0.768 / 0.742 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.018 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Mar 2026 | MYR 0.0100 |
| 10 Dec 2024 | MYR 0.0100 |
| 7 Sep 2020 | MYR 0.0100 |
| 11 Sep 2019 | MYR 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.